SOURCE: iiBIG

iiBIG

December 15, 2009 10:00 ET

BioPharma Leaders Define Best Practices in Outsourcing Clinical Operations at iiBIG's Global Clinical Trial Partnerships Forum

NEW YORK, NY--(Marketwire - December 15, 2009) - iiBIG and the newly formed Global BioPharmaceutical Advisory Board presents the 4th Annual Global Clinical Trial Partnerships: Optimizing Cross-Border Outsourcing conference, scheduled for March 1-2, 2010, in Princeton, NJ.

According to recent research by the Tufts Center for the Study of Drug Development, within the next three years, as much as 65% of all FDA-regulated clinical trials will be conducted outside of the United States. At the same time, the global market for clinical research is expected to grow by at least 8.5% per year. This growth -- coupled with declining resources within sponsor companies and increasing complexity of clinical protocols requiring more resources -- will lead to an increased demand for outsourcing globally.

With these statistics in mind, BioPharma leaders scheduled to present at this forum will deliver the latest strategies for optimizing global operations. Hear from:

--  Novartis and Sepracor on global patient recruitment strategies
--  AstraZeneca Latin America on specific challenges associated with
    working in the region and how to overcome them
--  Cell Therapeutics on strategies used for integrating CROs in the
    planning stages of development
--  ARIAD Pharmaceuticals and Sucampo Pharmaceuticals on their global
    feasibility data and how they selected the regions to work in
--  FibroGen, Daichii-Sankyo, and AstraZeneca on best practices for
    effective governance and how to optimize clinical operations
--  Astellas Pharma Development on lessons learned when running clinical
    trials in multi-regions
--  Allergan on successful tactics used in running clinical trials in Asia
    and other emerging markets
    

For complete agenda details and speaker roster: http://www.iibig.com/P1001

Conference sponsors include Thompson Hine LLP, Alpha Independent Review Board, D. Anderson & Company (DAC), eStudy Binder®, Medidata Solutions, Medpace, PharmaNet Development Group, PSI, and Quorum Review.

For more information on available sponsorship/exhibiting opportunities, please contact Kellie Swanstrom, VP, Business Development, iiBIG at 973-571-0867 or kellies@iibig.com.

About iiBIG

iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. We provide learning and networking settings with programs focused on the most pressing and timely issues facing decision-makers in today's global economy: http://www.iibig.com

Contact Information